| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Neurology (J.R.S.), Howard Hughes Medical Institute (B.L.B.), and Huntsman Cancer Institute (A.T.), University of Utah Medical School, Salt Lake City, Utah 84132
Address all correspondence and requests for reprints to: J. Robinson Singleton, M.D., Department of Neurology, University of Utah Medical School, Room 3R-152, 50 North Medical Drive, Salt Lake City, Utah 84132. E-mail: rob.singleton{at}hsc.utah.edu
In the critically ill, glucocorticoids induce myopathy, combining
profound protein catabolism and mild myotubular death. Insulin-like
growth factors (IGFs) inhibit muscle catabolism through activation of
phosphatidylinositol 3-kinase (PI3K). Using rat L6 myoblasts, we show
that IGF-I also acts through PI3K to inhibit apoptosis induced by
hyperosmolar metabolic stress with 300 mM mannitol. We find
that the glucocorticoid dexamethasone inhibits this antiapoptotic
effect of IGF-I by impairing PI3K signaling. Dexamethasone induces
overexpression of the PI3K subunit p85
, which, in turn, competes
with the complete PI3K heterodimer for binding at insulin receptor
substrate-1, inhibiting PI3K activation. Dexamethasone blocks
IGF-I-induced phosphorylation of Akt, a PI3K-dependent process.
Increased cellular p85
abundance, induced by either 10
µM dexamethasone or transient transfection with a plasmid
coding for p85
, significantly inhibits IGF-I rescue from apoptosis
induced by mannitol, as indicated by both loss of cell viability and
increased activity of caspase-3 by fluorogenic assay. Conversely,
constitutively active PI3K inhibits death induced by mannitol, even in
the presence of dexamethasone. These findings may have particular
relevance in the pathogenesis of acute steroid myopathy in critical
illness, in which catabolic glucocorticoid effects combine with acute
metabolic stressors, including sepsis, fasting, and chemical
denervation.
This article has been cited by other articles:
![]() |
L. A. Scheving, R. Buchanan, M. A. Krause, X. Zhang, M. C. Stevenson, and W. E. Russell Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G552 - G559. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. Hu, and S. R. Price Inhibition of PI3-kinase signaling by glucocorticoids results in increased branched-chain amino acid degradation in renal epithelial cells Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1874 - C1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Menezes, C. Sobreira, L. Neder, A. L. Rodrigues-Junior, and J. A. Baddini Martinez Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats J Appl Physiol, February 1, 2007; 102(2): 698 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Prelovsek, T. Mars, M. Jevsek, M. Podbregar, and Z. Grubic High dexamethasone concentration prevents stimulatory effects of TNF-{alpha} and LPS on IL-6 secretion from the precursors of human muscle regeneration Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1651 - R1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Sarzi-Puttini, F Atzeni, J Scholmerich, M Cutolo, and R H Straub Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3 Ann Rheum Dis, March 1, 2006; 65(3): 301 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chrysis, F. Zaman, A. S. Chagin, M. Takigawa, and L. Savendahl Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3'-Kinase Signaling Pathway Endocrinology, March 1, 2005; 146(3): 1391 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kritsch, S. Murali, M. L. Adamo, M. K. Clayton, and D. M. Ney Hypoenergetic High-Carbohydrate or High-Fat Parenteral Nutrition Induces a Similar Metabolic Response with Differential Effects on Hepatic IGF-I mRNA in Dexamethasone-Treated Rats J. Nutr., March 1, 2005; 135(3): 479 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leis, A. Page, A. Ramirez, A. Bravo, C. Segrelles, J. Paramio, D. Barettino, J. L. Jorcano, and P. Perez Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway Mol. Endocrinol., February 1, 2004; 18(2): 303 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Goncharova, C. K. Billington, C. Irani, A. V. Vorotnikov, V. A. Tkachuk, R. B. Penn, V. P. Krymskaya, and R. A. Panettieri Jr. Cyclic AMP-Mobilizing Agents and Glucocorticoids Modulate Human Smooth Muscle Cell Migration Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Rodgers, G. M. Weber, K. M. Kelley, and M. A. Levine Prolonged fasting and cortisol reduce myostatin mRNA levels in tilapia larvae; short-term fasting elevates Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1277 - R1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Adams Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation J Appl Physiol, September 1, 2002; 93(3): 1159 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kritsch, S. Murali, M. L. Adamo, and D. M. Ney Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R528 - R536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bernardi, D. L. Trump, W.-D. Yu, T. F. McGuire, P. A. Hershberger, and C. S. Johnson Combination of 1{alpha},25-Dihydroxyvitamin D3 with Dexamethasone Enhances Cell Cycle Arrest and Apoptosis: Role of Nuclear Receptor Cross-Talk and Erk/Akt Signaling Clin. Cancer Res., December 1, 2001; 7(12): 4164 - 4173. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |